Cabot (CBT) Cash & Equivalents (2009 - 2026)

Cabot (CBT) has reported Cash & Equivalents for 18 consecutive years, with $252.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 18.31% year-over-year to $252.0 million; the TTM figure through Mar 2026 stood at $252.0 million (up 18.31% YoY), while the FY2025 annual figure was $258.0 million, up 15.7% from the prior year.
• Cash & Equivalents improved to $252.0 million in Q1 2026 per CBT's latest filing, from $230.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $258.0 million in Q3 2025 and bottomed at $183.0 million in Q4 2024.
• Historically, Cash & Equivalents has averaged $219.2 million across 5 years, with a median of $215.0 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 47.26% — and 2024, when it slipped 25.0%.
• Cabot's Cash & Equivalents stood at $190.0 million in 2022, then grew by 28.42% to $244.0 million in 2023, then retreated by 25.0% to $183.0 million in 2024, then climbed by 25.68% to $230.0 million in 2025, then advanced by 9.57% to $252.0 million in 2026.
• Business Quant data shows CBT's Cash & Equivalents at $252.0 million in Q1 2026, $230.0 million in Q4 2025, and $258.0 million in Q3 2025.